Tango Biosciences Appoints Zachary Gurard-Levin to Board of Directors
Tango Biosciences, Inc., the premier contract research organization for custom affinity reagents by phage display, announced the appointment of Zachary Gurard-Levin, PhD, to its board of directors effective immediately.
Gurard-Levin brings over two decades of experience in assay development and driving successful research programs for biotech and pharma companies, including ten years as an executive at a drug discovery CRO. He is the founder and managing director of Tesserae Innovations LLC, an organization that specializes in developing data-driving research plans, amplifying business development, and communicating value with clarity and confidence to ensure life science companies achieve their full commercial potential. He is also a board member of the Society for Laboratory Automation and Screening (SLAS).
“Dr. Gurard-Levin’s in-depth experience in commercializing innovative technologies and expertise in CRO technical marketing and effective communication will support our growth strategy in custom affinity reagents and binding assays,” states Michael Scholle, CEO for Tango Biosciences. “His expertise in developing creative solutions for high-quality assays and a vast network within the life science industry will be invaluable to Tango Biosciences.”
“I am thrilled to be on the board of directors and help guide Tango Biosciences as it expands its commercial operation and adds new capabilities to accelerate the development of world-class peptides and antibodies,” adds Gurard-Levin.
Tesserae Innovations Debuts at SLAS2025 in San Diego
We are thrilled to announce that Tesserae Innovations will make its premiere at SLAS2025, the leading conference for laboratory automation and screening, in San Diego!
Founded by Zack Gurard-Levin, PhD Tesserae Innovations understands that becoming a successful life science company requires more than great science. Having successfully navigated the lifecycle from the SLAS Innovation AveNEW program–a launchpad for groundbreaking start-ups–becoming a longstanding SLAS exhibitor and sponsor, to company acquisition, Zack is excited to bring his expertise and empower companies to achieve their full commercialization potential.
Meet with Zack at SLAS2025 to learn how Tesserae Innovations can guide your path to success with strategies that integrate cutting-edge technology, impactful marketing, business development, and creative communication solutions.
Children’s Book Now Available on Amazon.com
Zack Gurard-Levin, PhD, a seasoned life science executive, tackles communicating complex topics in an entirely new medium – children’s literature! Zack has channeled his passion for impactful storytelling into authoring a children’s book that teaches vital life lessons. “Chloe Doesn’t Clam Up” delves into themes of self-acceptance, empathy, and the transformative power of collaboration, aiming to inspire young minds to embrace what makes them unique and work together to create something extraordinary. Zack’s unique ability to blend meaningful insight with creative expression ensures this book will resonate with children and adults alike, fostering meaningful conversations and personal growth.